Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial

Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology, and the site revision label advances from v3.7.1 to v3.7.2. The study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T23:59:19.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The site's displayed revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:28:58.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating access to the record is blocked. This does not modify the underlying study data but prevents viewing the content.
    Difference
    16%
    Check dated 2026-09-23T00:00:15.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision updated to v3.7.0, indicating a new build of the site; there is no indication of changes to the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-09-16T00:14:06.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 at the bottom of the page, signaling a minor maintenance update. It does not modify the study details or other substantive content.
    Difference
    0.1%
    Check dated 2026-09-01T19:37:13.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a maintenance update to the page's underlying tooling. This change does not modify the study content or its presentation.
    Difference
    0.1%
    Check dated 2026-08-11T18:33:33.000Z thumbnail image

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.